Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Liver Transpl. 2017 Sep;23(9):1143–1152. doi: 10.1002/lt.24813

Table 1.

Characteristics of the cohort at LT

Characteristic at LT Median (IQR) or n (%) (n=7,220)
Age 59 (52–66)

Female 2,428 (34%)
Male 4,792 (66%)

White 5,332 (74%)
Black 550 (8%)
Asian 276 (4%)
Hispanic/Latino 985 (14%)
Multi-racial/other 77 (1%)

Status 1 at transplant 81 (1%)

Body mass index (BMI) 27.8 (24.6–32.0)

Hepatitis C 2,574 (36%)
Cholestatic liver disease 526 (7%)
Non-cholestatic liver disease 2,288 (32%)
Hepatocellular carcinoma 1,228 (17%)
Other liver disease 604 (8%)

Lab MELD at transplant 17 (13–24)

Albumin at transplant (g/dl) 2.9 (2.5–3.4)

Diabetes 2,057 (28%)

Dialysis 316 (4%)

No ascites 1,346 (19%)
Slight ascites 4,010 (56%)
Moderate ascites 1,864 (26%)

Portal vein thrombosis at transplant 546 (8%)

History of TIPSS 768 (11%)

In intensive care unit (ICU) at LT 504 (7%)
Hospitalized, not in ICU 970 (13%)
Not hospitalized 5,746 (80%)

Renal risk index (RRI) 1.60 (0.99–2.84)

Donor risk index (DRI) 1.45 (1.22–1.75)